Neoadjuvant chemotherapy for locally advanced esophageal cancer comparing cisplatin and 5-fluorouracil versus docetaxel plus cisplatin and 5-fluorouracil: a propensity score matching analysis

被引:0
|
作者
Noriyuki Nishiwaki
Kazuhiro Noma
Tomoyoshi Kunitomo
Masashi Hashimoto
Naoaki Maeda
Shunsuke Tanabe
Kazufumi Sakurama
Yasuhiro Shirakawa
Toshiyoshi Fujiwara
机构
[1] Okayama University Graduate School of Medicine,Department of Gastroenterological Surgery
[2] Dentistry and Pharmaceutical Sciences,Department of Surgery
[3] Shigei Medical Research Institute,undefined
[4] Hiroshima City Hiroshima Citizens Hospital,undefined
来源
Esophagus | 2022年 / 19卷
关键词
Esophageal cancer; Chemotherapy; Docetaxel; Cisplatin; 5-Fluorouracil;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:626 / 638
页数:12
相关论文
共 50 条
  • [41] Safety results of a phase 3 study of comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in chemoradiotherapy for locally advanced esophageal carcinoma (ESO-Shanghai 1).
    Chen, Yun
    Zhao, Kuaile
    Ye, Jingjun
    Zhu, Zhengfei
    Zhao, Weixin
    Li, Ling
    Zhou, Pahang
    Wu, Chaoyang
    Tang, Huarong
    Xu, Gang
    Lin, Qin
    Li, Jiancheng
    Xia, Yi
    Li, Yunhai
    Zhang, Zhen
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [42] Neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-RT) for locally advanced esophageal squamous cell carcinoma
    Ken Sasaki
    Yasuto Uchikado
    Itaru Omoto
    Takaaki Arigami
    Yusaku Osako
    Masahiro Noda
    Hiroshi Okumura
    Kosei Maemura
    Ryutaro Higashi
    Takashi Yoshiura
    Shoji Natsugoe
    [J]. Cancer Chemotherapy and Pharmacology, 2019, 83 : 581 - 587
  • [43] Tolvaptan for Hyponatremia Induced by Chemotherapy With Docetaxel, Cisplatin, and 5-Fluorouracil
    Hoshi, Akane
    Momo, Kenji
    Yamazaki, Kimiyasu
    Otsuka, Koji
    Aoki, Takeshi
    Murakami, Masahiko
    Sasaki, Tadanori
    [J]. AMERICAN JOURNAL OF THERAPEUTICS, 2022, 29 (03) : E380 - E383
  • [44] Febrile neutropenia in patients with esophageal cancer receiving combination chemotherapy of docetaxel, cisplatin, and 5-fluorouracil
    Nomura, H.
    Hatogai, K.
    Suzuki, S.
    Maki, Y.
    Mochizuki, N.
    Tanaka, M.
    Kojima, T.
    Saito, S.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S247 - S247
  • [45] Sequential chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil in patients with locally advanced head and neck cancer
    Janinis, J
    Papadakou, M
    Panagos, G
    Panousaki, A
    Georgoulias, V
    Hatzidaki, D
    Lefantzis, D
    Dokianakis, G
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2001, 24 (03): : 227 - 231
  • [46] Induction Chemotherapy with Docetaxel/Cisplatin/5-Fluorouracil for Patients with Node-Positive Esophageal Cancer
    Watanabe, Masayuki
    Nagai, Yohei
    Kinoshita, Kuichi
    Saito, Seiya
    Kurashige, Junji
    Karashima, Ryuichi
    Hirashima, Kotaro
    Sato, Nobutaka
    Imamura, Yu
    Hiyoshi, Yukiharu
    Baba, Yoshifumi
    Iwagami, Shiro
    Miyamoto, Yuji
    Iwatsuki, Masaaki
    Hayashi, Naoko
    Baba, Hideo
    [J]. DIGESTION, 2011, 83 (03) : 146 - 152
  • [47] Long-term results of a randomized controlled trial comparing neoadjuvant Adriamycin, cisplatin, and 5-fluorouracil vs docetaxel, cisplatin, and 5-fluorouracil followed by surgery for esophageal cancer (OGSG1003)
    Sugimura, Keijiro
    Yamasaki, Makoto
    Yasuda, Takushi
    Yano, Masahiko
    Hirao, Motohiro
    Fujitani, Kazumasa
    Kimura, Yutaka
    Miyata, Hiroshi
    Motoori, Masaaki
    Takeno, Atsushi
    Shiraishi, Osamu
    Makino, Tomoki
    Kii, Takayuki
    Tanaka, Koji
    Satoh, Taro
    Mori, Masaki
    Doki, Yuichiro
    [J]. ANNALS OF GASTROENTEROLOGICAL SURGERY, 2021, 5 (01): : 75 - 82
  • [48] A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma—the ESO-shanghai 1 trial protocol
    Yun Chen
    Zhengfei Zhu
    Weixin Zhao
    Ling Li
    Jinjun Ye
    Chaoyang Wu
    Huarong Tang
    Qin Lin
    Jiancheng Li
    Yi Xia
    Yunhai Li
    Jialiang Zhou
    Kuaile Zhao
    [J]. Radiation Oncology, 13
  • [49] Weekly Docetaxel, Cisplatin, and 5-Fluorouracil as Initial Therapy for Patients With Advanced Gastric and Esophageal Cancer
    Overman, Michael J.
    Kazmi, Syed M.
    Jhamb, Jagriti
    Lin, E.
    Yao, James C.
    Abbruzzese, James L.
    Ho, Linus
    Ajani, Jaffer
    Phan, Alexandria
    [J]. CANCER, 2010, 116 (06) : 1446 - 1453
  • [50] Phase II study of chemoselection with docetaxel plus 5-fluorouracil and cisplatin induction chemotherapy and subsequent conversion surgery for locally advanced unresectable esophageal cancer
    Yokota, Tomoya
    Kato, Ken
    Hamamoto, Yasuo
    Tsubosa, Yasuhiro
    Ogawa, Hirofumi
    Ito, Yoshinori
    Hara, Hiroki
    Ura, Takashi
    Kojima, Takashi
    Chin, Keisho
    Hironaka, Shuichi
    Kii, Takayuki
    Kojima, Yasushi
    Akutsu, Yasunori
    Matsushita, Hisayuki
    Kawakami, Kentaro
    Mori, Keita
    Nagai, Yushi
    Asami, Chika
    Kitagawa, Yuko
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)